Indefinite Delivery Contract SPE2DU25D9808

The federal contract IDV award SPE2DU25D9808 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The IDC was awarded as part of the DLA Troop Support Medical Supply Chain's upcoming solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, which are intended to establish multiple regional primary supplier and backup supplier awards valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period and three 30-month option periods, allowing the DLA to issue firm fixed-price delivery orders for the required pharmaceutical items across a diverse product portfolio to support normal day-to-day operations as well as planned and unplanned contingency needs of military health facilities globally.